Brain injury care guidelines for first responders released

Over 50 experts—clinicians, researchers, policymakers, first responders and representatives from agencies that employ and advocate for them—have reached consensus on the first recommendations for the recognition, diagnosis and management of traumatic brain injury in first responders.
Publishing today (Oct. 16, 2026) in The Journal of Head Trauma Rehabilitation, the 52 authors agreed to 28 recommendations designed to help first responders, health care professionals and agencies work toward five primary goals: timely recognition of traumatic brain injury (TBI), safe recovery, operational readiness, reduced stigma and first responder–centered care.

Lab-designed molecule reduces amyloid beta, the protein linked to Alzheimer’s disease, in mice

A research team led by the Molecular and Cellular Neurobiotechnology group at the Institute for Bioengineering of Catalonia (IBEC), in collaboration with Míriam Royo's laboratory at the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), the University of Barcelona (UB) and the Institute for Research in Biomedicine (IRB Barcelona), has identified a synthetic peptide that reduces the production of amyloid beta (Aβ).